Sunshine Guojian Pharmaceutical (shanghai) Co., Ltd.
Clinical trials sponsored by Sunshine Guojian Pharmaceutical (shanghai) Co., Ltd., explained in plain language.
-
New hope for hidden arthritis pain: phase 3 trial launches
Disease control Not yet recruitingThis study tests a new drug called 608 for people with a type of arthritis in the spine that doesn't show up on X-rays (non-radiographic axial spondyloarthritis). The goal is to see if 608 can reduce pain and improve function better than a placebo. About 380 adults will take part…
Phase: PHASE3 • Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 12:01 UTC
-
New hope for ulcerative colitis sufferers: experimental drug enters Mid-Stage trial
Disease control Not yet recruitingThis study tests an experimental drug called SSGJ-627 in 288 adults with moderate to severe ulcerative colitis, a chronic bowel disease causing inflammation and symptoms like diarrhea and bleeding. The goal is to see if the drug can safely control the disease and improve symptoms…
Phase: PHASE2 • Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 14:04 UTC